Search clinical trials for: BGB-283

Total 2554 results

Bayer
Merck Sharp & Dohme LLC

Terminated

Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases

Carcinoma, Non-Small-Cell Lung

Spain, Belgium, Netherlands, United States
Emory University
National Cancer Institute (NCI)

Recruiting

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell Carcinoma

United States
Amsterdam UMC, location VUmc

Active, not recruiting

Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy (RaRe)

Prostate Cancer Metastatic to Bone

Netherlands
Nantes University Hospital

Terminated

Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer (RITCOLON)

Metastatic Colorectal Cancer

France
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Hidradenitis Suppurativa

China
BioAge Labs, Inc.

Terminated

Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

Covid19

United States, Brazil, Argentina
BioAge Labs, Inc.

Withdrawn

Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging

Anemia

Australia
CAGE Bio Inc.
ethica Clinical Research Inc.

Completed

CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea

Rosacea

United States
Assistance Publique - Hôpitaux de Paris
BPIfrance; CarThera

Completed

Blood Brain Barrier Opening in Alzheimer' Disease (BOREAL1)

Alzheimer Disease

France
Bayer

Completed

PK in Pts With HRPC & Skeletal Metastes

Prostatic Neoplasms

United Kingdom
Helsinki University Central Hospital
DexCom, Inc.

Not yet recruiting

Happy Bob App in 9-13 Year-old Children

Type1diabetes
Bright Minds Biosciences Pty Ltd

Completed

A 3-Part Study to Evaluate the Safety, Tolerability, PK, and Food Effect of BMB-101 in Healthy Volunteers

Healthy

Australia
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Defengrui Biotechnology Co. Ltd

Completed

A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients

COVID-19

China
Giselle Sholler
Cortice Biosciences, Inc.

Completed

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

Medulloblastoma | Neuroblastoma | Relapse

United States
October 6 University

Completed

A Comparative Study Between Three Different Plating Techniques in Management of Mandibular Parasymphyseal Fractures.

Mandibular Fractures

Egypt
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bayer; Dendreon

Completed

Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC

Prostate Cancer

United States
Lee's Pharmaceutical Limited

Unknown

Phase I Clinical Study of Oral TG02 Capsule in the Treatment of Recurrent / Progressive High-grade Glioma Patients

High-grade Gliomas

China
Celgene

Completed

A Phase 1 Open-Label Study to Evaluate the Metabolism and Excretion of CC-223 and the Effect of Food on the Pharmacokinetics of CC-223 in Healthy Male Adult Subjects (AME/FE)

Safety and Pharmacokinetics in Healthy Volunteer Subjects

United States
M.D. Anderson Cancer Center
Cortice Biosciences, Inc.

Terminated

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

Brain Cancer

United States
Aptose Biosciences Inc.

Completed

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours

Advanced or Metastatic Solid Tumours

United States
Nantes University Hospital
Direction Générale de l'Offre de Soins

Completed

CCA of SGB PCR Versus SGB Culture at 35-38 SA in the Optimization of Intrapartum Antibiotic Prophylaxis (DEPIST2P)

Streptococcus Agalactiae

France
Cancer Institute and Hospital, Chinese Academy...
Fudan University; Peking Union Medical College Hospital; Chinese PLA General... and other collaborators

Not yet recruiting

Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)

Rectal Cancer

China
Association Pour La Recherche des Thérapeutiques...

Unknown

Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL) (EIFFEL)

Bone Metastases | Clear-cell Metastatic Renal Cell Carcinoma

France
The Cleveland Clinic
Ohio State University Comprehensive Cancer Center

Completed

Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)

Familial Adenomatous Polyposis

United States
EyebioKorea, Inc.

Completed

Safety, Tolerability and Pharmacokinetics of EB-203 Eye Drops in Healthy Volunteers

Healthy

Korea, Republic of
Boehringer Ingelheim

Completed

Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers

Healthy
Cortice Biosciences, Inc.

Completed

Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies

Neoplasms | Non-Hodgkin's Lymphoma | Hodgkin's Disease

United States
Dupont Applied Biosciences

Unknown

Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors

HIV Infections

United States
BeiGene

Completed

Study to Evaluate the Effect of Food on the Pharmacokinetics of a BGB-3111 in Healthy Subjects

Healthy Volunteers

Australia
ICM Biotech Australia Pty Ltd.

Recruiting

A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis

Osteoarthritis, Knee

Australia
Blueprint Medicines Corporation

Active, not recruiting

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

Mast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic Neoplasm

United States, Canada, United Kingdom, France, Netherlands, Italy, Spain, Austria, Denmark, Germany, Norway, Poland
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth Disease

United States
Cortice Biosciences, Inc.

Completed

Study of TPI 287 in Patients With Advanced Malignancies

Neoplasms | Hodgkin Disease | Non-Hodgkin Lymphoma

United States
Dr. Sabrina Overhagen

Active, not recruiting

BGP Stent as Bridging Stent in FEVAR

Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture | Abdominal Aortic Aneurysm, Without Mention of Rupture

Germany
David C. Rotzinger

Recruiting

Impact of Fast-rotation Coronary CT in Patients Undergoing Aortic Stenosis Workup (FAST-CCT)

Cardiovascular Diseases | Aortic Valve Stenosis | Coronary Stenosis

Switzerland
Tufts Medical Center
Bayer; Ohio State University Comprehensive Cancer Center; Lahey Clinic; Henry Ford...

Active, not recruiting

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

Metastatic Castrate Resistant Prostate Cancer

United States
Bayer

Terminated

Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

Breast Neoplasms

Spain, Canada, United States, Finland, Austria, Singapore, Czechia, Israel, Korea, Republic of, Netherlands, Taiwan, United Kingdom, Poland, Germany, Hong Kong, Denmark, Switzerland, Ireland, France, Norway
Sen-Jam Pharmaceutical

Completed

Safety and Efficacy of a Combination Product for the Prevention of Veisalgia

Veisalgia
University of Michigan

Recruiting

Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients

Inflammatory Bowel Diseases

United States
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Defengrei Biotechnology Co.,Ltd

Completed

Safety and Tolerability of BDB-001 Injection in Healthy Subjects

Healthy

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Defengrei Biotechnology Co.,Ltd

Completed

Tolerability and Safety of BDB-001 Injection in Healthy Subjects

Healthy

China
The First Affiliated Hospital with Nanjing Medical...

Recruiting

TISLELIZUMAB Combined With Anlotinib and Chemotherapy(XELOX) in the Treatment of Advanced Gastric Carcinoma (TAXE-GC)

Gastric Cancer

China
BeiGene

Completed

Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants

Healthy Volunteers

United States
BeiGene

Completed

Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma (MAGNOLIA)

Marginal Zone Lymphoma | MZL

China, Australia, Italy, France, New Zealand, Czechia, United Kingdom, United States, Korea, Republic of
BeiGene

Completed

Relative Bioavailability of Zanubrutinib Tablets Compared to Capsules and Effects of Food on the Pharmacokinetics of the Tablet in Healthy Adults

Healthy Volunteers

United States
ModernaTX, Inc.

Completed

A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19

SARS-CoV-2

United States
iOnctura

Completed

A Study to Assess an ATX Inhibitor (IOA-289) in Healthy Volunteers

Healthy

Italy
MedSIR
Bayer

Completed

Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status

Prostate Cancer

Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder

Major Depressive Disorder
University of Maryland, Baltimore
Maryland Industrial Partnerships; Telcare, Inc

Terminated

Smart Glucose Meter Project

Type 1 Diabetes | Type 2 Diabetes

United States

Search clinical trials for: BGB-283

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations